https://lonafarnibinhibitor.co....m/the-responsibility
While statin treatment continues for a substantial period, there is only a slight connection to the emergence of non-diabetic idiopathic neuropathy. Importantly, the potential of statins to improve diabetic peripheral neuropathy (PN) is rooted in their anti-inflammatory, antioxidant, and immunomodulatory properties. To properly interpret research on statins and peripheral neuropathy (PN), one must delineate the underlying mechanism